Odonate Therapeutics, Inc. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • November 27th, 2017 • Odonate Therapeutics, LLC • Pharmaceutical preparations • New York
registration of the Undersigned’s Securities, or file or cause to be filed any registration statement in connection therewith, under the Securities Act of 1933, as amended, or publicly announce the intention to engage in any of the foregoing transactions. The foregoing restriction is expressly agreed to preclude the undersigned from engaging in any hedging or other transaction which is designed to or which reasonably could be expected to lead to or result in a sale or disposition of the Undersigned’s Securities even if the Undersigned’s Securities would be disposed of by someone other than the undersigned. Such prohibited hedging or other transactions would include without limitation any short sale or any purchase, sale or grant of any right (including without limitation any put or call option) with respect to any of the Undersigned’s Securities or with respect to any security that includes, relates to, or derives any significant part of its value from the Undersigned’s Securities.
INDEMNIFICATION AGREEMENTIndemnification Agreement • November 27th, 2017 • Odonate Therapeutics, LLC • Pharmaceutical preparations • Delaware
This Indemnification Agreement (this “Agreement”) is entered into as of November [ ], 2017 (the “Effective Date”) by and between Odonate Therapeutics, Inc., a Delaware corporation (the “Company”), and [ ] (the “Indemnitee”).
LIMITED LIABILITY COMPANY AGREEMENT OF ODONATE HOLDINGS, LLCLimited Liability Company Agreement • November 27th, 2017 • Odonate Therapeutics, LLC • Pharmaceutical preparations • Delaware
This Limited Liability Company Agreement (this “Operating Agreement”) of Odonate Holdings, LLC (“Odonate Holdings”) is made effective as of November 27, 2017 (the “Effective Date”), with respect to the holders of Units (each a “Member,” and collectively, the “Members”).
